Abstract
This is a Comment on Greg Myers' paper on the writing and rewriting of patent applications by two biological scientists. It draws on data from our own study of patenting in UK public sector biosciences. While agreeing with much that Myers says, we place the issues in a wider context of developing relationships between industry and academe. The emergence of new networks blurs boundaries, and makes apparently separate arenas less distinct.
Get full access to this article
View all access options for this article.